A rare case of PSA-negative metastasized prostate cancer to the stomach with serum CEA and CA19-9 elevation: a case report
Abstract Background Metastatic cancer to the stomach is relatively rare. Prostate-specific antigen (PSA) is a reliable biomarker used in the screening and management of patients with prostate cancer. However, it is difficult to definitively diagnose a PSA-negative metastatic gastric tumor of prostat...
Saved in:
Main Authors: | Koji Shindo, Kenoki Ohuchida, Taiki Moriyama, Fumio Kinoshita, Yutaka Koga, Yoshinao Oda, Masatoshi Eto, Masafumi Nakamura |
---|---|
Format: | Article |
Language: | English |
Published: |
Japan Surgical Society
2020-12-01
|
Series: | Surgical Case Reports |
Subjects: | |
Online Access: | https://doi.org/10.1186/s40792-020-01074-7 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Numerous lymph node metastases in early gastric cancer without preoperatively enlarged lymph nodes: a case report
by: Chikanori Tsutsumi, et al.
Published: (2020-01-01) -
CEA-Functionalized Gold Nanoparticles as a Nanovaccine Platform: In Vitro Evaluation of Cytocompatibility, Cellular Uptake, and Antigen Processing
by: Razvan-Septimiu Zdrehus, et al.
Published: (2025-06-01) -
Edukacja i terapia w asyście psa
by: Kamila Witerska, et al.
Published: (2025-07-01) -
Combination of PSA density and MLR improves the diagnostic accuracy of prostate cancer
by: Feng Guo, et al.
Published: (2025-07-01) -
PROSTATE CANCER WITH A HIGH BASELINE PSA LEVEL AFTER COMBINED TREATMENT
by: A. T. Asratov, et al.
Published: (2017-12-01)